Tippins J R, Greenwald S E, Lever M J, MacIntyre I, Morris H R
Department of Biochemistry, Imperial College of Science and Technology, London.
Neuropeptides. 1989 Feb-Mar;13(2):95-102. doi: 10.1016/0143-4179(89)90005-x.
The ability of CGRP to increase blood flow in the coronary circulation of the anaesthetized pig was studied in a constant pressure perfusion model. Human alpha-CGRP, when infused close-arterially into the left anterior descending coronary artery perfused at constant pressure, produced a marked and prolonged dose-related increase in coronary flow, at doses above 10 pmol min-1. The gradient of the flow/pressure curves at each dose increased with an increase in pressure, indicating a drop in the resistance of the coronary bed. No significant change was observed in heart rate, left ventricle pressure, mean arterial pressure or cardiac output.
在恒压灌注模型中研究了降钙素基因相关肽(CGRP)增加麻醉猪冠状动脉循环血流量的能力。当以接近动脉内的方式将人α-CGRP注入以恒压灌注的左前降支冠状动脉时,在剂量高于10 pmol min-1时,冠状动脉血流量出现显著且持续的剂量相关增加。每个剂量下流量/压力曲线的斜率随压力增加而增大,表明冠状动脉床阻力下降。心率、左心室压力、平均动脉压或心输出量未观察到显著变化。